NEW COAS IN ONCOLOGY GUIDE
QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.
Read the GuideOur experts provide medical device clients with leading strategic measurement services, qualitative and quantitative research and patient journey studies, PRO outcomes analyses, rare disease research, and PRO regulatory support services.
The FDA encourages the integration of patient-reported outcome (PRO) instruments in the development, evaluation, and surveillance of medical device studies. For medical device manufacturers, determining the best PRO for your study can be challenging, but QualityMetric’s scientific team can help.
Our team can use its decades of experience in the development, modification, validation, implementation, and analysis of PROs in more than 60 therapeutic categories to help you select or adapt a PRO. These experts provide our medical device clients with leading strategic measurement services, qualitative and quantitative research and patient journey studies, PRO outcomes analyses, rare disease research, and PRO regulatory support services.
